Fluent Biosciences Inc.
Fluents breakthrough technology enables powerful single cell analysis in every laboratory without the use of complex instrumentation, so you can focus on advancing your research instead of managing expensive technology. Our first Single Cell RNA product for 3 gene expression is a flexible, cost-effective and complete workflow solution from sample preparation through data analysis that is perfect for studies across cancer, immunology, neuroscience and infectious disease.
Last updated on
About Fluent Biosciences Inc.
Founded
2018Estimated Revenue
$0-$1MEmployees
11-50Funding / Mkt. Cap
$23MCategory
Industry
Medical DevicesLocation
City
WatertownState
MassachusettsCountry
United StatesFluent Biosciences Inc.
Find your buyer within Fluent Biosciences Inc.